More recently, SIRT1 activating compound SRT3025 was shown to protect against atherosclerosis by modulating LDL-degrading enzyme proprotein convertase subtilisin/kexin type 9 (PCSK9) in LDLr−/− mice [60]. The gene discussed is PCSK9; the disease is atherosclerosis.